Stoke Therapeutics (STOK) Profit After Tax (2022 - 2025)
Historic Profit After Tax for Stoke Therapeutics (STOK) over the last 4 years, with Q3 2025 value amounting to -$38.3 million.
- Stoke Therapeutics' Profit After Tax fell 4508.89% to -$38.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.6 million, marking a year-over-year increase of 13846.78%. This contributed to the annual value of -$89.0 million for FY2024, which is 1501.26% up from last year.
- Per Stoke Therapeutics' latest filing, its Profit After Tax stood at -$38.3 million for Q3 2025, which was down 4508.89% from -$23.5 million recorded in Q2 2025.
- In the past 5 years, Stoke Therapeutics' Profit After Tax ranged from a high of $112.9 million in Q1 2025 and a low of -$38.3 million during Q3 2025
- In the last 4 years, Stoke Therapeutics' Profit After Tax had a median value of -$25.7 million in 2022 and averaged -$16.2 million.
- Data for Stoke Therapeutics' Profit After Tax shows a peak YoY increase of 52799.35% (in 2025) and a maximum YoY decrease of 4508.89% (in 2025) over the last 5 years.
- Over the past 4 years, Stoke Therapeutics' Profit After Tax (Quarter) stood at -$25.7 million in 2022, then decreased by 5.08% to -$27.0 million in 2023, then skyrocketed by 61.12% to -$10.5 million in 2024, then crashed by 265.84% to -$38.3 million in 2025.
- Its Profit After Tax stands at -$38.3 million for Q3 2025, versus -$23.5 million for Q2 2025 and $112.9 million for Q1 2025.